Literature DB >> 18688056

Evidence-based standards for cancer pain management.

Sydney M Dy1, Steven M Asch, Arash Naeim, Homayoon Sanati, Anne Walling, Karl A Lorenz.   

Abstract

High-quality management of cancer pain depends on evidence-based standards for screening, assessment, treatment, and follow-up for general cancer pain and specific pain syndromes. We developed a set of standards through an iterative process of structured literature review and development and refinement of topic areas and standards and subjected recommendations to rating by a multidisciplinary expert panel. Providers should routinely screen for the presence or absence and intensity of pain and should perform descriptive pain assessment for patients with a positive screen, including assessment for likely etiology and functional impairment. For treatment, providers should provide pain education, offer breakthrough opioids in patients receiving long-acting formulations, offer bowel regimens in patients receiving opioids chronically, and ensure continuity of opioid doses across health care settings. Providers should also follow up on patients after treatment for pain. For metastatic bone pain, providers should offer single-fraction radiotherapy as an option when offering radiation, unless there is a contraindication. When spinal cord compression is suspected, providers should treat with corticosteroids and evaluate with whole-spine magnetic resonance imaging scan or myelography as soon as possible but within 24 hours. Providers should initiate definitive treatment (radiotherapy or surgical decompression) within 24 hours for diagnosed cord compression and should follow up on patients after treatment. These standards provide an initial framework for high-quality evidence-based management of general cancer pain and pain syndromes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688056     DOI: 10.1200/JCO.2007.15.9517

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  33 in total

1.  Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology.

Authors:  Yolanda Escobar Álvarez; César A Rodríguez Sánchez; Fernando Caballero Martínez; Virginia Recuero Cuervo; Carlos Camps Herrero
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  [Is opioid-induced immunosuppression a clinically relevant problem? Innocent until proven guilty!].

Authors:  S C Azad
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

3.  Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain.

Authors:  Juan M Jimenez-Andrade; Aaron P Bloom; James I Stake; William G Mantyh; Reid N Taylor; Katie T Freeman; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 4.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

Review 5.  International Myeloma Working Group recommendations for global myeloma care.

Authors:  H Ludwig; J S Miguel; M A Dimopoulos; A Palumbo; R Garcia Sanz; R Powles; S Lentzsch; W Ming Chen; J Hou; A Jurczyszyn; K Romeril; R Hajek; E Terpos; K Shimizu; D Joshua; V Hungria; A Rodriguez Morales; D Ben-Yehuda; P Sondergeld; E Zamagni; B Durie
Journal:  Leukemia       Date:  2013-10-09       Impact factor: 11.528

Review 6.  Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management.

Authors:  Gee Su Yang; Natalie M Barnes; Debra E Lyon; Susan G Dorsey
Journal:  Semin Oncol Nurs       Date:  2019-05-10       Impact factor: 2.315

7.  Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.

Authors:  Mary E Cooley; David F Lobach; Ellis Johns; Barbara Halpenny; Toni-Ann Saunders; Guilherme Del Fiol; Michael S Rabin; Pamela Calarese; Isidore L Berenbaum; Ken Zaner; Kathleen Finn; Donna L Berry; Janet L Abrahm
Journal:  J Pain Symptom Manage       Date:  2013-05-13       Impact factor: 3.612

8.  Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases.

Authors:  Anne M Walling; Phillip J Beron; Tania Kaprealian; Patrick A Kupelian; Neil S Wenger; Susan A McCloskey; Christopher R King; Michael Steinberg
Journal:  J Palliat Med       Date:  2017-02-23       Impact factor: 2.947

9.  Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.

Authors:  Jinlu Dai; Honglai Zhang; Andreas Karatsinides; Jill M Keller; Kenneth M Kozloff; Dana T Aftab; Frauke Schimmoller; Evan T Keller
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

10.  An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.

Authors:  Magdi Hanna; Alberto Tuca; John Thipphawong
Journal:  BMC Palliat Care       Date:  2009-09-15       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.